SpectraScience Announces Expected SEC Filing Dates

SAN DIEGO, CA--(Marketwired - Apr 2, 2014) - SpectraScience, Inc. (OTCQB: SCIE) announced today that the Company plans to file its late filings with the Securities and Exchange Commission in accordance with the schedule listed below:


Period Ending		Expected Filing Date
10Q September 30, 2013		April 16, 2014
10K December 31, 2013		May 28, 2014
10Q March 31, 2014		June 16, 2014

In order to prevent inadvertent disclosure while catching up on filings, the next investor update call will be scheduled after the company is once again current in its submissions. It is expected the next business update conference call will be scheduled for late June.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT® Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

Contacts: Media and Investors: SpectraScience, Inc. Lowell Giffhorn CFO Phone: (858) 847-0200 x2019 Email: Email Contact

SpectraScience (CE) (USOTC:SCIE)
Historical Stock Chart
From Dec 2024 to Jan 2025